CD274 and cancer: Significantly, the cancer cells treated with 5IOX1 + DOX or IPLD allowed PBMCs to proliferate with the PI of 40.9% or 35.8% due to the IOX1-enhanced cytotoxicity and suppressed PD-L1 expression.